Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant BEP vs carboplatin in clinical stage I seminoma
2014-004075-23Phase 3Active
- Sponsor
- St. Olavs University Hospital
- Start
- Jan 2015
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bleomycin, etoposide, cisplatin and carboplatin in Pure seminoma and testicular neoplasm (2 arms), sponsored by St. Olavs University Hospital. Primary endpoint: Relapse rate. Started Jan 2015; status: active.
02
Drugs
bleomycinetoposidecisplatincarboplatin
03
Conditions
Pure seminomatesticular neoplasm
Beyond the preview
Go deeper on 2014-004075-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004075-23.